Global AI for Drug Discovery Market Opportunities & Forecast Global AI for Drug Discovery Market Opportunities | Page 8

9.1.3.
North America AI for Drug Discovery Devices Market by Therapeutic
9.1.3.1. Metabolic Disease
9.1.3.2. Cardiovascular Disease
9.1.3.3. Oncology
9.1.3.4. Neurodegenerative Diseases
9.1.3.5.
9.1.4.
Others
North America AI for Drug Discovery Devices Market by End User
9.1.4.1.
9.1.4.2.
Pharmaceutical Companies
Biopharmaceutical Companies
9.1.4.3. Academic and Research Institutes
9.1.4.4. Others
9.2.
Europe AI for Drug Discovery Devices Market Revenue Forecast till 2025
9.2.1.
Europe AI for Drug Discovery Devices Market by Drug Type (Option 2:
25% customization)
9.2.1.1. Small Molecule
9.2.1.2. Large Molecules
9.2.2.
Europe AI for Drug Discovery Devices Market by Technology
9.2.2.1. Deep Learning
9.2.2.2. Machine Learning
9.2.3.
Europe AI for Drug Discovery Devices Market by Therapeutic
9.2.3.1. Metabolic Disease
9.2.3.2. Cardiovascular Disease
9.2.3.3. Oncology
9.2.3.4. Neurodegenerative Diseases
9.2.3.5.
9.2.4.
Others
Europe AI for Drug Discovery Devices Market by End User
9.2.4.1.
9.2.4.2.
Pharmaceutical Companies
Biopharmaceutical Companies
9.2.4.3. Academic and Research Institutes
9.2.4.4. Others
9.3.
Asia-Pacific AI for Drug Discovery Devices Market Revenue Forecast till